When U.S. Sen. Elizabeth Warren rolled out details of her Medicare for All plan at the beginning of November, she didn’t merely answer her fellow Democratic presidential contenders, who were clamoring to know how she proposed to pay for it.
George Washington University is suing its corporate partner in one of the Washington region’s foremost hospitals, crossing a new threshold in a dispute that could affect plans to build a new medical center east of the Anacostia River.
In the largest local biotech deal of the year, French pharmaceutical giant Sanofi is acquiring La Jolla’s cancer drug startup Synthorx for $2.5 billion. The 5-year-old startup has been working in the field of synthetic biology, expanding the genetic code to give its researchers more building blocks to create novel drugs. Synthorx just went public in late 2018, raising $131 million in its initial public offering.
Entrepreneur Andrew Yang on Tuesday released a plan to lower prescription drug costs, which includes allowing Medicare to negotiate drug prices and creating public manufacturing facilities to make generic drugs.
California is preparing for a much smaller budget surplus next year because of its ongoing feud with the Trump administration, one of the state’s chief budget writers said Monday. California is projected to have a $7 billion surplus, with $3 billion of it available to spend on recurring programs.
A record 25% of Americans say they or a family member put off treatment for a serious medical condition in the past year because of the cost, up from 19% a year ago and the highest in Gallup's trend. Another 8% said they or a family member put off treatment for a less serious condition, bringing the total percentage of households delaying care due to costs to 33%, tying the high from 2014.